A novel combination of sitagliptin and melatonin ameliorates T2D manifestations: studies on experimental diabetic models.
R PatelN ParmarS P PalitN RathwaRasheedunnisa BegumPublished in: Journal of endocrinological investigation (2023)
The combination treatment is superior to monotherapies in the management of T2D.